MUC6 and metastatic malignant neoplasm in the lymph nodes: In GAS patients, we did not observe significant differences in clinicopathological findings, such as patient age, FIGO stage, lymph node metastasis and ascites cytology, between cases positive or negative for MUC6, αGlcNAc and α4GnT markers (Table 2).